[1. Feyrter, F., Harmann, G. (1963). On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (gelatinosum) mammae (in German). Frankf Z Pathol. 73:24-39.]Search in Google Scholar
[2. Cubilla, A.L., Woodfruff, J.M. (1977). Primary carcinoid tumor of the breast: a report of eight patients. Am Surg Pathol. 1:283.]Search in Google Scholar
[3. Ellis, I.O., Schnitt, S.J., Sastre-Garau, X. (2003). Invasive breast carcinoma. In: Tavassoli F.A. and Devilee P. (Eds.), World Health Organizationof Classification of Tumors. Pathology andGenetics of Tumours of the Breast and FemaleGenital Organs (pp. 30-34). IARC Press, Lyon.]Search in Google Scholar
[4. Lopez-Bonet, E., Alonso-Ruano, M., Barraza, G., Vazquez-Martin, A., Bernado, L., Menendez, J.A. (2008). Solid neuroendocrine breast carcinomas: Incidence, clinico-pathological features and Immunohistochemical profiling. Oncol Rep. 20:1369-1374.]Search in Google Scholar
[5. Bussolati, G., Badve S. (2012). Carcinomas with neuroendocrine features. In Lakhani, S.R., Ellis, I.O., Schnitt, S.J., Tan, P.H.& van deVijver, M.J. (Eds.) WHO Classification of Tumours of theBreast (pp.62-63). IARC Press, Lyon, France.]Search in Google Scholar
[6. Hammond, M.E., Hayes, D.F., Allred, D.C., Dowsett, M., Hagerty, K.L., Badve, S. (2010) American Society of Clinical Oncology/ College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Arch Pathol Lab Med. 134(7):e48-e72.]Search in Google Scholar
[7. Antonio, C.W., Hammond, M.H., Schwartz, J.N., Hagerty, K.L., Allred, C. (2007). American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Arch Pathol Lab Med. 131(1):18-43.]Search in Google Scholar
[8. Dowsett, M., Nielsen, T.O., A’Hern, R., Bartlett, J., Coombes, C., Cuzick, J., Ellis, M. (2011). Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group. J Natl CancerInst. 103(22):1656-1664.]Search in Google Scholar
[9. Sapino, A., Righi, L., Cassoni, P., Papotti, M., Gugliotta, P., Bussolati, G. (2001). Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol. 14: 768-776.]Search in Google Scholar
[10. Righi, L., Sapino, A., Marchio, C., Papotti, M., Bussolati, G. (2010). Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin Diagn Pathol. 27:69-76.]Search in Google Scholar
[11. Gao, L.X., Liu, G., Li, L., Lin, H.Y., Jin, H., Cheng, J., Jin, M.L., Ding, H.Y. (2011). Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping. ZhonghuaBing Li Xue Za Zhi. 40(9):604-9.]Search in Google Scholar
[12. Monfair, F. (2007) Special types of breast carcinomas. In Monfair, F. (Ed.): Essential ofDiagnostic Breast Pathology - A PracticalApproach(pp.223-317). Berlin, Heidelberg, Spring.]Search in Google Scholar
[13. Tang, F., Wei, B., Tian, Z., Gilcreas, M.Z., Huo, L., Albarracin, C.T., Resetkova, E., Zhang, H., Sahin, A., Chen, J., Bu. H., Abraham, S., Wu, J. (2011). Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology. 59:106-115.]Search in Google Scholar
[14. Alkaied, H., Harris, K., Azab, B., Dai, Q. (2012). Primary neuroendocrine breast cancer, how much do we know so far?. Med Oncol. DOI: 10.1007/ s12032-012-0222-z.]Search in Google Scholar
[15. Perou, C.M., Sorlie, T., Eisen, M.B. (2000). Molecular portraits of human breast tumours. Nature. 406(6797): 747-752.]Search in Google Scholar
[16. Sorlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 98:10869-10874.]Search in Google Scholar
[17. Goldhirsch, A., Wood, W.C., Coates, A.S., Gelber, R.D., Thurlimann, B., Senn, H.J. & Panel members (2011). Strategies for subtypes- dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology. 22: 1736-1747.]Search in Google Scholar
[18. Weigelt, B., Horlings, H.M., Kreike, B., Hayes, M.M., Hauptmann, M., Wessels, L.F., de Jong, D.,Van de Vijver, M.J., Van’t Veer, L.J., Peterse, J.L. (2008). Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 216:141-150.]Search in Google Scholar
[19. Sorlie, T., Tibshirani, R., Parker, J., Hastie, T. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 100(14): 8418-8423.]Search in Google Scholar
[20. Voduc, K.D., Cheang, M.C.U., Tyldesley, S., Gelmon, K., Nielsen, T.O. & Kennecke, H. (2010). Breast Cancer Subtypes and the Risk of Local and Regional Relapse. J Clin Oncol. 28(10):1684-1691.]Search in Google Scholar
[21. McIntire, M., Siziopikou, K., Patil, J., Gattuso, P. (2008). Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine needle aspiration. Diagn Cytopathol. 36:54-57.]Search in Google Scholar
[22. Tian, Z., Wei, B., Tang, F., Wei, W., Gilcrease, M.Z., Huo, L., Albarracin, C.T., Resetkova, E. (2011). Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 42(8):1169-77. ]Search in Google Scholar
